New NICE recommendations in metastatic non-squamous NSCLC
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Empirical cotrimoxazole least costly therapy for dysuria
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Patient navigation worth integrating into cancer care
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Financial toxicity after cancer diagnosis and treatment
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Reclassifying oral contraceptives to pharmacy-only cost  effective
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Costs of industry-sponsored medical device trials in Canada
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

OM-85 cost saving in ARTI prevention in pre-school children
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Polypharmacy and comorbidities increase ADRs and costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Use of long-acting reversible contraceptives increases in USA
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

US states suing generic drug makers over price conspiracy
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Different approaches to assess benefits of oncology drugs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

PHARMAC funds longer-acting treatments for haemophilia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Physostigmine safely reduces resource use in delirium
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Hookworm infections in Kenya: costs of community-wide treatment
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Asthma substantial economic burden in Greece
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Geography determines cost effectiveness of birth intervention
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Global health financing increasing but disparities persist
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Factors impacting HTA requirement in Ireland
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

PHARMAC proposing more clarity on funding decisions
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Diabetes prevention programme modest success, cost neutral
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Economics of omalizumab responder identification in asthma
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Are costly new treatments for diabetic retinopathy cost effective?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Procalcitonin-guided therapy reduces antibacterial costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Disproportionate hospital costs in elderly cancer cases
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Medically tailored meals decrease healthcare use and costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Cost burden of RSV in US infants
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

FDA added-sugar label: health and economic gains substantial
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Panic disorder with or without agoraphobia costly in Germany
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Assessing Medicare and patient spending among elderly with CML
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Fulvestrant 500mg cost effective in HR+ advanced breast cancer in UK
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Universal 36-week scan for breech presentation cost effective
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Extended-pulsed fidaxomicin cost  effective for CDI
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2019 Category: Drugs & Pharmacology Source Type: news

Smoking increases treatment failure and costs of cancer
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

Denosumab cost effective in patients with multiple myeloma
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

PrEP with 6-monthly testing cost  effective for MSM and PWID
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

ICER reports on peanut allergy, RA and spinal muscular atrophy
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

Variation in medical costs among people living with HIV/AIDS in US
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

High hospitalisation costs for heart  failure in Japan
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

Mismatch between R & amp;D budget and burden of disease in Korea
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

Reimbursement decisions on drugs for renal cell carcinoma
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

UK Cancer Drugs Fund: new framework reviewed
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

Early colonoscopy cost  effective after childhood cancer
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

Economic burden of CF substantial in Germany, and likely to rise
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

HPV cervical screening cost effective in New Zealand
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

Impact of price changes after loss of exclusivity for MS treatments
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

National Pharmacare in Canada: Budget 2019
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

Costly multi-trauma rehab has limited benefits
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

Avelumab and palbociclib listed on Australian PBS
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

Cost effectiveness of biomarker tests for preterm labour
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

Assessing economic burden of HPV9-related diseases in Italy
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2019 Category: Drugs & Pharmacology Source Type: news